Market Updates

Cymbiotika Named on 2026 Inc. 5000 List for Fifth Consecutive Year

The company, known for its liposomal and liquid formats, has continued to expand its product portfolio and retail presence.

Cymbiotika has been named in the 2026 Inc. 5000, an annual ranking of the fastest-growing private companies in America, for the fifth consecutive year.

“Being named to the Inc. 5000 for the fifth consecutive year is an incredible milestone for Cymbiotika and a reflection of what our team has built together,” said Shahab Elmi, co-founder and CEO. “To have earned this recognition every year we’ve been eligible makes it especially meaningful. From the beginning, our focus has been on raising the standard for wellness through innovation, quality and an unwavering commitment to our community, and we’re incredibly proud of the continued growth that has come from that mission.”

The digitally native supplement brand has expanded its product portfolio and retail presence since its founding in 2019 and is known for its liposomal and liquid formats. The brand continues to reach consumers through its direct-to-consumer business, as well as through availability at Target, Ulta Beauty, and Whole Foods Market.

“Every company on the Inc. 5000 has a story of perseverance, smart decision-making, and a refusal to sit still,” said Mike Hofman, editor-in-chief of Inc. “Their growth reflects more than strong financial performance–it reflects creativity, resilience, and the customer focus required to build companies that make a lasting impact. We congratulate all honorees on this significant achievement.”

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters